Article
Christopher Lynch’s Article, “Federal Rescheduling Sets The Stage For Marijuana Business Acquisitions As Pharma And Ag Firms Eye Industry (Op-Ed)," Was Published In Marijuana Moment
The FDA's rescheduling of marijuana from Schedule I to Schedule III signals accepted medical use and lower abuse potential, creating new opportunities for business consolidation. As pharmaceutical and agricultural firms eye the cannabis industry, companies must strategically position themselves as either consolidators or attractive acquisition targets in this evolving landscape.

Dickinson Wright PLLC